These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29487354)

  • 1. miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival.
    Arvidsson Y; Rehammar A; Bergström A; Andersson E; Altiparmak G; Swärd C; Wängberg B; Kristiansson E; Nilsson O
    Mod Pathol; 2018 Aug; 31(8):1302-1317. PubMed ID: 29487354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets.
    Andersson E; Arvidsson Y; Swärd C; Hofving T; Wängberg B; Kristiansson E; Nilsson O
    Mod Pathol; 2016 Jun; 29(6):616-29. PubMed ID: 26965582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
    Li SC; Essaghir A; Martijn C; Lloyd RV; Demoulin JB; Oberg K; Giandomenico V
    Mod Pathol; 2013 May; 26(5):685-96. PubMed ID: 23328977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs associated with small bowel neuroendocrine tumours and their metastases.
    Miller HC; Frampton AE; Malczewska A; Ottaviani S; Stronach EA; Flora R; Kaemmerer D; Schwach G; Pfragner R; Faiz O; Kos-Kudła B; Hanna GB; Stebbing J; Castellano L; Frilling A
    Endocr Relat Cancer; 2016 Sep; 23(9):711-26. PubMed ID: 27353039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine.
    Heverhagen AE; Legrand N; Wagner V; Fendrich V; Bartsch DK; Slater EP
    Neuroendocrinology; 2018; 106(4):312-317. PubMed ID: 28848144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study.
    Mairinger FD; Ting S; Werner R; Walter RF; Hager T; Vollbrecht C; Christoph D; Worm K; Mairinger T; Sheu-Grabellus SY; Theegarten D; Schmid KW; Wohlschlaeger J
    Mod Pathol; 2014 Dec; 27(12):1632-40. PubMed ID: 24875640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
    Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma.
    Bowden M; Zhou CW; Zhang S; Brais L; Rossi A; Naudin L; Thiagalingam A; Sicinska E; Kulke MH
    Oncotarget; 2017 Aug; 8(33):54331-54344. PubMed ID: 28903345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
    Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
    BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating MicroRNAs in Small-bowel Neuroendocrine Tumors: A Potential Tool for Diagnosis and Assessment of Effectiveness of Surgical Resection.
    Malczewska A; Frampton AE; Mato Prado M; Ameri S; Dabrowska AF; Zagorac S; Clift AK; Kos-Kudła B; Faiz O; Stebbing J; Castellano L; Frilling A
    Ann Surg; 2021 Jul; 274(1):e1-e9. PubMed ID: 31373926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors.
    Malczewska A; Kidd M; Matar S; Kos-Kudla B; Modlin IM
    Neuroendocrinology; 2018; 107(1):73-90. PubMed ID: 29566385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor.
    Karpathakis A; Dibra H; Pipinikas C; Feber A; Morris T; Francis J; Oukrif D; Mandair D; Pericleous M; Mohmaduvesh M; Serra S; Ogunbiyi O; Novelli M; Luong T; Asa SL; Kulke M; Toumpanakis C; Meyer T; Caplin M; Meyerson M; Beck S; Thirlwell C
    Clin Cancer Res; 2016 Jan; 22(1):250-8. PubMed ID: 26169971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies.
    Petrillo M; Zannoni GF; Beltrame L; Martinelli E; DiFeo A; Paracchini L; Craparotta I; Mannarino L; Vizzielli G; Scambia G; D'Incalci M; Romualdi C; Marchini S
    Ann Oncol; 2016 Apr; 27(4):625-34. PubMed ID: 26782955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas.
    Sandhu V; Bowitz Lothe IM; Labori KJ; Lingjærde OC; Buanes T; Dalsgaard AM; Skrede ML; Hamfjord J; Haaland T; Eide TJ; Børresen-Dale AL; Ikdahl T; Kure EH
    Mol Oncol; 2015 Apr; 9(4):758-71. PubMed ID: 25579086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
    Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
    BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of proliferation-related miRNAs in pancreatic neuroendocrine neoplasms.
    Grolmusz VK; Kövesdi A; Borks K; Igaz P; Patócs A
    Eur J Endocrinol; 2018 Oct; 179(4):219-228. PubMed ID: 30299890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survival.
    Lee HS; Chen M; Kim JH; Kim WH; Ahn S; Maeng K; Allegra CJ; Kaye FJ; Hochwald SN; Zajac-Kaye M
    Int J Cancer; 2014 Jul; 135(1):128-37. PubMed ID: 24347111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA-3653 Is a Potential Tissue Biomarker for Increased Metastatic Risk in Pancreatic Neuroendocrine Tumours.
    Gill P; Kim E; Chua TC; Clifton-Bligh RJ; Nahm CB; Mittal A; Gill AJ; Samra JS
    Endocr Pathol; 2019 Jun; 30(2):128-133. PubMed ID: 30767148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.
    Simbolo M; Vicentini C; Mafficini A; Fassan M; Pedron S; Corbo V; Mastracci L; Rusev B; Pedrazzani C; Landoni L; Grillo F; Cingarlini S; Rindi G; Luchini C; Scarpa A; Lawlor RT
    Virchows Arch; 2018 Dec; 473(6):709-717. PubMed ID: 30219970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
    Edfeldt K; Hellman P; Westin G; Stalberg P
    BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.